Clinical Trial Update: A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing orforglipron (LY3502970) to dapagliflozin in adults with type 2 diabetes on metformin has completed; results are not provided in the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Forxiga (dapagliflozin)
• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED